Wall Street Beat
Symmetry Medical sells its OEM biz to Tecomet for $450M
Symmetry Medical’s (NYSE:SMA) going through some big changes, selling off its orthopedics components division and spinning out its surgical business.
Cardinal Health struggles but beats The Street in Q4
Ohio healthcare giant Cardinal Health (NYSE:CAH) got no Wall Street love after posting estimate-beating earnings today.
Hologic’s CEO praises its activist investor
Ex-CEO Pignatelli backs down, but not out, in spat with Biolase
Report: Lantheus spikes IPO plans
Lantheus Medical Imaging reportedly spiked an initial public offering it hoped would raise $125 million, citing "poor market conditions," Renaissance Capital reported.
Teleflex delivers a beat-and-raise Q2
Smith & Nephew plans to reveal new strategy for mature markets | Medtech Wall Street news for the week of July 28, 2014
T2 Biosystems boosts IPO cap to $78.2M
Massachusetts-based T2 Biosystems raised its hopes for its upcoming initial public offering, raising its maximum aggregate take to $78.2 million if shares sell at $17 apiece.
Edwards: Q2 brings double-digit sales bump, a major Medtronic settlement and a rosier outlook on the year
Edwards Lifesciences (NYSE:EW) bumped its expectations for the year after posting a strong 2nd quarter with significant increases in its sales and profits.
Philips’ healthcare business suffers in Q2
Philips Healthcare (NYSE:PHG) had a tough 2nd quarter with a shutdown of a manufacturing facility in Cleveland taking some of the wind out of the sales for the entire company.